Home LiteratureArticle Details
PMID: 225427 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Inhibition of 80S initiation complex formation by infection with poliovirus.

The Journal of general virology ·Vol. 43 ·No. 2 ·1979-05-00 ·Pages 441-5

Ehrenfeld E, Manis S

Abstract

Anisomycin has been shown to stabilize ribosome initiation complexes containing messenger RNA and met-tRNAf met to high salt conditions. Extracts from HeLa cells treated with 5 X 10(-7) M-anisomycin for 15 min accumulate 80S initiation complexes which can be detected by their absorbance in sucrose gradients. Poliovirus-infected cells fail to form the 80S initiation complex early after infection, when inhibition of host cell protein synthesis occurs. These complexes re-form later in infection after virus RNA is synthesized. No re-formation occurs in the absence of virus replication. Thus, the step in protein synthesis inhibited by poliovirus precedes the entry of components into the 80S initiation complex.

MeSH Terms
Anisomycin/pharmacology HeLa Cells Humans Methionine Neoplasm Proteins/biosynthesis Peptide Chain Initiation, Translational/drug effects Poliovirus/growth & development RNA, Messenger/metabolism RNA, Neoplasm/metabolism RNA, Transfer, Amino Acyl/metabolism Ribosomes/metabolism Virus Replication
Chemicals
Neoplasm Proteins RNA, Messenger RNA, Neoplasm RNA, Transfer, Amino Acyl Anisomycin Methionine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Ehrenfeld E
Manis S
Article Info
Journal
The Journal of general virology
Abbr.
J Gen Virol
ISSN
0022-1317
Published
1979-05-00
Pages
441-5
Language
English
Region
England
NLM ID
0077340
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com